Patent details

Basic Information

Publication number:

EP1904490

PCT Application Number:

PCT/GB/2006/002654

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP067557793

PCT Publication Number:

WO/2007/010235

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ETHANOLAMINE SALT OF N- (3-METHOXY-5-METHYLPYRAZIN-2YL) -2- (4- Ö1 , 3 , 4-0XADIAZ0LE-2-YLÜPHENYL) PYRIDINE-3- SULPHONAMIDE

French Title of Invention:

SEL ETHANOLAMINE DE N-(3-METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-Ö1,3,4-OXADIAZOLE-2-YLÜPHENYL)PYRIDINE-3-SULFAMIDE

German Title of Invention:

ETHANOLAMINSALZ VON N-(METHOXY-5-METHYLPYRAZIN-2-YL)-2-(4-Ö1,3,4-OXADIAZOL-2-YLÜPHENYL)PYRIDIN-3-SULFONAMID

SPC Number:

Dates

Filing date:

17/07/2006

Grant date:

29/09/2010

EP Publication Date:

29/09/2010

PCT Publication Date:

25/01/2007

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/04/2008

EP B1 Publication Date:

29/09/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/07/2012

Expiration date:

17/07/2026

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/07/2006

 

 

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

Name:

VAN MALDEREN JOELLE

From:

23/11/2010

Address:

ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

GOOD Catherine

Address:

United Kingdom (GB)

2

Name:

HOGAN Phillip John

Address:

United Kingdom (GB)

3

Name:

MONTGOMERY Frank

Address:

United Kingdom (GB)

Priority

Priority Number:

0514743

Priority Date:

19/07/2005

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07D 413/14;

Filing date	Document type	Number of pages